Information Provided By:
Fly News Breaks for January 5, 2017
MCK
Jan 5, 2017 | 06:24 EDT
JPMorgan analyst Lisa Gill downgraded McKesson to Neutral citing her cautious near-term view on the broader pharmaceutical distribution sector. The analyst sees uncertainties around branded drug price inflation, generic deflation and the overall competitive environment. She lowered her price target for the shares to $169 from $171.